Johannes Breuning is a Scientific Director at GSK, where he leads programs developing novel antibody-based cancer therapies. His work focuses on bispecific T-cell engagers and antibody drug conjugates, leveraging his Ph. D. from the University of Oxford and a strong background in T-cell immunology and drug discovery.
During his postdoctoral studies, he won a €30, 000 innovation award for a research project investigating the use of Chimeric Antigen Receptors (CARs) for cancer immunotherapy.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Explore more public profiles from related professionals.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.